Do Adults With Obesity Feel Pain More Intensely? Do Adults With Obesity Feel Pain More Intensely?
Adults with excess weight or obesity reported higher pain levels, emphasizing the need to address obesity in pain management, according to a systematic review and meta-analysis.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Gut Bacteria's Influence on Obesity Differs in Men and Women Gut Bacteria's Influence on Obesity Differs in Men and Women
Different bacterial species affect the onset and development of obesity in men vs women.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Semaglutide Beneficial in HFpEF Patients With Diabetes Semaglutide Beneficial in HFpEF Patients With Diabetes
In patients with HFpEF and obesity, symptom reduction and weight loss provided by semaglutide extends to those with diabetes, suggest new data from the STEP-HFpEF DM trial.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 8, 2024 Category: Internal Medicine Tags: Cardiology Source Type: news
Chelation Therapy Provides No Benefit Post-MI Chelation Therapy Provides No Benefit Post-MI
Chelation therapy to remove potentially toxic levels of lead was not associated with a reduction in CV events in post-MI patients with diabetes in the TACT2 trial.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 7, 2024 Category: Endocrinology Tags: Cardiology Source Type: news
Wegovy Helps HFpEF Patients With Diabetes Mellitus
(MedPage Today) -- ATLANTA -- Weight loss and heart failure benefits with semaglutide (Wegovy) extended to patients with obesity-related heart failure with preserved ejection fraction (HFpEF) who have type 2 diabetes, the STEP-HFpEF DM trial showed... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 7, 2024 Category: Cardiology Source Type: news
Electronic BCG Sock Detects Unhealthy Gait
An electronic sock that detects an unhealthy walking style linked with diabetes and poor circulation shows promise for preventing foot ulcers and amputation (Source: Disabled World)
Source: Disabled World - April 7, 2024 Category: Disability Tags: Home Medical Devices Source Type: news
Sanofi looks for accelerated growth in India; plans fast-tracking of product pipeline
Sanofi, a leading French pharmaceutical company, aims to expand its presence in the Indian market by introducing new drugs, enhancing localization efforts, and collaborating with domestic firms. Managing Director Rodolfo Hrosz highlights the significant growth potential in India and emphasizes the company's focus on addressing the diabetes segment. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 7, 2024 Category: Pharmaceuticals Source Type: news
Miracle diabetes jab Ozempic 'halves severe heart failure symptoms' in 'paradigm shift' in battle against deadly condition
Celebrities like Elon Musk (pictured) have admitted to taking the miracle diabetes jab Ozempic in a bid to slim down. (Source: the Mail online | Health)
Source: the Mail online | Health - April 6, 2024 Category: Consumer Health News Source Type: news
Study shows Wegovy easing heart failure symptoms for patients with diabetes
Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart failure symptoms for patients with diabetes in the latest large trial to support use of the drug to treat health conditions linked to obesity. Patients who took Wegovy reported less fatigue, less leg swelling, were…#novonordiskas #novo #danish #jama (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
Wegovy ’s heart benefits are not just linked with weight loss, new study suggests
People with obesity-related heart failure and diabetes can get substantial heart-health benefits from weight-loss drug Wegovy, even if they don’t shed many pounds on the medication, according to new research. (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
Novo ’s Wegovy Aids Heart Failure Patients With Diabetes in Study
(Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
Apr 05 2024 This Week in Cardiology Apr 05 2024 This Week in Cardiology
Statins and diabetes, AAD in patients with heart disease, tricuspid valve interventions, and an ACC preview are the topics John Mandrola, MD, discusses in this week ’s podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 5, 2024 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Specialty Care Access Not Equal Among Teens With Diabetes
(MedPage Today) -- Commercially insured youths with type 2 diabetes were less likely to see specialists compared with their counterparts with type 1 diabetes, a cross-sectional study of claims data indicated.
In propensity score-weighted analyses... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 5, 2024 Category: Cardiology Source Type: news
Why Heart Disease Research Still Favors Men
Published in partnership with The Fuller Project, a nonprofit newsroom dedicated to the coverage of women’s issues around the world.
Katherine Fitzgerald had just arrived at the party. Before she could even get a drink, she threw up and broke out in a sweat. “I was dizzy. I couldn’t breathe. I had heart pain,” Fitzgerald says.
She knew she was having a heart attack.
[time-brightcove not-tgx=”true”]
What she didn’t know then was that the heart attack could have been prevented. Fitzgerald, a health-conscious, exercise-loving lawyer, should have been taking statin drugs to s...
Source: TIME: Health - April 5, 2024 Category: Consumer Health News Authors: Maggie Fox Tags: Uncategorized freelance healthscienceclimate Source Type: news
5 Things to Know About Continuous Glucose Monitors 5 Things to Know About Continuous Glucose Monitors
Recently, the FDA approved the first OTC continuous glucose monitors. Beverly Tchang, MD, shares how these can be an important step toward personalized medicine.Medscape Diabetes & Endocrinology (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - April 5, 2024 Category: Universities & Medical Training Tags: Diabetes & Endocrinology Source Type: news
